Ditchcarbon
  • Contact
  1. Organizations
  2. Vetoquinol SA
Public Profile
Pharmaceutical Preparation Manufacturing
FR
updated 9 months ago

Vetoquinol SA Sustainability Profile

Company website

Vetoquinol SA, a prominent player in the animal health industry, is headquartered in France and operates extensively across Europe, North America, and Asia. Founded in 1933, the company has established itself as a trusted provider of veterinary pharmaceuticals and nutritional products, focusing on the health and well-being of pets and livestock. With a diverse portfolio that includes anti-infectives, pain management solutions, and nutritional supplements, Vetoquinol stands out for its commitment to innovation and quality. The company’s dedication to research and development has led to significant advancements in animal care, positioning it as a leader in the veterinary market. Notable achievements include a strong global presence and a reputation for reliability among veterinarians and pet owners alike.

DitchCarbon Score

How does Vetoquinol SA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

28

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Vetoquinol SA's score of 28 is lower than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.

47%

Let us know if this data was useful to you

Vetoquinol SA's reported carbon emissions

Vetoquinol SA, headquartered in France, currently does not report specific carbon emissions data for the most recent year, as indicated by the absence of emissions figures. The company is identified as a current subsidiary and does not inherit emissions data from a parent organization. In terms of climate commitments, Vetoquinol SA has not established documented reduction targets or initiatives, nor does it participate in recognised frameworks such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). This lack of specific targets suggests that the company may still be in the early stages of formalising its climate strategy. As a player in the veterinary pharmaceutical industry, Vetoquinol SA is positioned within a sector increasingly focused on sustainability and carbon reduction. However, without concrete emissions data or reduction commitments, it remains unclear how the company plans to address its carbon footprint in the future.

How Carbon Intensive is Vetoquinol SA's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Vetoquinol SA's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Vetoquinol SA's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Vetoquinol SA is in FR, which has a very low grid carbon intensity relative to other regions.

Vetoquinol SA's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Vetoquinol SA has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Vetoquinol SA's Emissions with Industry Peers

Huvepharma N.V.

NL
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

Heska Corporation

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Eli Lilly and Company

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 4 hours ago

Let us know if this data was useful to you

Usage Policy

You're welcome to quote or reference data from this page, but please include a visible link back to this URL.

Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.

See our License Agreement for more details.

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251211.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
Use CaseSBTi-aligned baselining & progress trackingSupplier EngagementClimate-informed sourcing strategyEmission ReportingSustainable Finance
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelogWhitepaper
AboutTeamCareersLicense AgreementPrivacy